三鑫医疗：接受中信证券等投资者调研

Group 1 - The core viewpoint of the article is that Sanxin Medical (SZ 300453) has provided insights during an investor meeting held on August 12, 2025, where key executives addressed investor inquiries [2] - For the first half of 2025, Sanxin Medical's revenue composition shows that the medical device sector accounted for 99.78% of total revenue, while other businesses contributed only 0.22% [2]